Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Trinh

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Cell Death & Disease|March 1, 2018
Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitorsRaeeka Khamari, Anne Trinh, Pierre Elliott Gabert, et al.
Molecular Metabolism|December 5, 2021
Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cellsAnne Trinh, Raeeka Khamari, Quentin Fovez, et al.
Nature Communications|May 13, 2020
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancerJennifer Y Ge, Shaokun Shu, Mijung Kwon, et al.
Cancer Research|September 28, 2016
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical OutcomesAndriy Marusyk, Doris P Tabassum, Michalina Janiszewska, et al.
Cancer Research|June 27, 2019
<i>EN1</i> Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain MetastasisGuillermo Peluffo, Ashim Subedee, Nicholas W Harper, et al.
Cancer Immunology Research|April 21, 2022
Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast CancerCarlos R Gil Del Alcazar, Anne Trinh, Maša Alečković, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2016
Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by ImmunohistochemistryAnne Trinh, Kari Trumpi, Felipe De Sousa E Melo, et al.
BMC Cancer|April 13, 2022
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancerSanne Ten Hoorn, Cynthia Waasdorp, Martijn G H van Oijen, et al.
Nature Medicine|April 16, 2013
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesionsFelipe De Sousa E Melo, Xin Wang, Marnix Jansen, et al.
JCI Insight|April 22, 2021
The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancerMichalina Janiszewska, Shayna Stein, Otto Metzger Filho, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cell Death & Disease|March 1, 2018
Glucose metabolism and NRF2 coordinate the antioxidant response in melanoma resistant to MAPK inhibitorsRaeeka Khamari, Anne Trinh, Pierre Elliott Gabert, et al.
Molecular Metabolism|December 5, 2021
Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cellsAnne Trinh, Raeeka Khamari, Quentin Fovez, et al.
Nature Communications|May 13, 2020
Acquired resistance to combined BET and CDK4/6 inhibition in triple-negative breast cancerJennifer Y Ge, Shaokun Shu, Mijung Kwon, et al.
Cancer Research|September 28, 2016
Spatial Proximity to Fibroblasts Impacts Molecular Features and Therapeutic Sensitivity of Breast Cancer Cells Influencing Clinical OutcomesAndriy Marusyk, Doris P Tabassum, Michalina Janiszewska, et al.
Cancer Research|June 27, 2019
<i>EN1</i> Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain MetastasisGuillermo Peluffo, Ashim Subedee, Nicholas W Harper, et al.
Cancer Immunology Research|April 21, 2022
Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast CancerCarlos R Gil Del Alcazar, Anne Trinh, Maša Alečković, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2016
Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by ImmunohistochemistryAnne Trinh, Kari Trumpi, Felipe De Sousa E Melo, et al.
BMC Cancer|April 13, 2022
Serum-based measurements of stromal activation through ADAM12 associate with poor prognosis in colorectal cancerSanne Ten Hoorn, Cynthia Waasdorp, Martijn G H van Oijen, et al.
Nature Medicine|April 16, 2013
Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesionsFelipe De Sousa E Melo, Xin Wang, Marnix Jansen, et al.
JCI Insight|April 22, 2021
The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancerMichalina Janiszewska, Shayna Stein, Otto Metzger Filho, et al.
Pageof 6